GDRX GoodRx Holdings, Inc. Class A Common Stock SERVICES-COMPUTER PROCESSING & DATA PREPARATION Best Data Processing Stocks 2026 →

GoodRx (GDRX) Stock: Buy, Sell, or Hold?

$3.51
-0.04 (-0.99%) â–ŧ
5d: -5.78% 30d: +1.59% 90d: -5.78%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (73%)
Quality Score
53/100
Position
FAIR
30-Day Fair Range
$3.36 – $3.58
Position: FAIR
Forward P/E & Valuation
10.1x STRETCHED
vs 7.6x historical avg
Wall Street Target
$3.95
+11.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.33 / $3.80
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: GDRX is fairly priced but lacks strong directional signals. At 9.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Nov 3, 2026 at $3.50 · last confirmed Nov 10, 2026

Strength: 5.7/10

Get Alerted When GDRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$4.31
Based on 10.1% avg growth
INTRINSIC VALUE TODAY
$2.68
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: GDRX is currently trading at $3.50, which is considered fair relative to its 30-day fair value range of $3.36 to $3.58. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.1) compared to its historical average (7.6). At these levels, the market is pricing in 9.9% annual earnings growth.

Technical Outlook: Technically, GDRX is in a uptrend. Immediate support is located at $3.33, while resistance sits at $3.80.

Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.95 (+11.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $3.36 - $3.58
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 73.3%

Trading Range & Key Levels

30-Day Trading Range $3.36 - $3.58
Current vs Trading Range FAIR
Support Level $3.33
Resistance Level $3.80
Current Trend Uptrend
Technical data as of Nov 10, 2026

Protect Your Profits

Holding GDRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (48/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($3.95)
  • BULLISH: Expecting earnings turnaround to 9.9% growth with -1.3% revenue growth
  • WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 10.06
Wall Street Target $3.95 (+11.6%)
Revenue Growth (YoY) -1.3%
Earnings Growth (YoY) -44.5%
Profit Margin 2.1%
Valuation Premium vs History +9.9% premium
PE vs Historical 10.1 vs 7.6 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +9.9% (market-implied from PE analysis)
1-Year Target $3.89 (+10%)
2-Year Target $4.28 (+21%)
3-Year Target $4.70 (+33%)
3-Yr Target (if PE normalizes) (PE: 10→8) PE COMPRESSION $3.55 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 16.2%) $10.96 (+210%)
Base: (SPY PE: 10.1, Growth: 16.2%) $5.55 (+57%)
Bear: (PE: 7.6, Growth: 16.2%) $4.19 (+19%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (10x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Forward PE: 10.29 | Forward EPS (Implied): $0.34
Bull Case $4.27 (+21%)
Analyst growth 15.0%, PE expands to 10.8
Base Case $3.54 (0%)
Market implied 0.0%, PE stable at 10.3
Bear Case $2.71 (-24%)
Severe decline -15.0%, PE contracts to 9.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share GDRX Analysis

Share this live GDRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (GDRX)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary: Trader on StockTwits expresses optimism about $GDRX, referencing earnings (eps) and potential breakout from a tight trading range.
Key Retail Themes: Positive earnings Breakout potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:39 AM ET
Data refreshes hourly during market hours. Next update: 11:39 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for GDRX.

Create Free Account

Already have an account? Log In

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VEEV
Veeva Systems Inc Class A
BUY
29 analysts
$320 48 HOLD
WAY
Waystar Holding Corp. Coâ€Ļ
STRONG BUY
23 analysts
$35 35 SELL
BTSG
BrightSpring Health Servâ€Ļ
STRONG BUY
18 analysts
$83 39 SELL
HNGE
Hinge Health, Inc.
STRONG BUY
17 analysts
$135 37 SELL
PRVA
Privia Health Group Inc
STRONG BUY
18 analysts
$31 30 SELL

Advanced GDRX Option Strategies

Professional options setups generated by AI based on today's GDRX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive GDRX Research Pages
GDRX Technical Chart GDRX Price Prediction GDRX Intrinsic Value DCF GDRX Earnings Date GDRX Investment Advisor GDRX Fair Price Analyzer GDRX Options Chain GDRX Options Advisor GDRX Options Analysis GDRX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals